Skip to main content

Efficacy and safety Overview

DUPIXENT was studied in
multiple measures of COPD

Studied in two phase 3 clinical trials with over 1800 patients1,2

Not actual
DUPIXENT patients.

Studied in two phase 3 clinical trials with over 1800 patients1,2

Not actual
DUPIXENT patients.

SEE THE RESULTS OF DUPIXENT ON EXACERBATIONS, LUNG FUNCTION, AND QUALITY OF LIFEAS WELL AS
ITS DEMONSTRATED SAFETY PROFILE1,2

COPD, chronic obstructive pulmonary disease.

DUPIXENT MyWay®

Get patient access support and information about benefits investigations,
prior authorizations, and medical necessity and appeal letters

EXPLORE PATIENT SUPPORT
SERVICES

Contact a Field Representative

Connect with a DUPIXENT Field Representative to get answers
to your product-related questions

Contact a rep